A.H.M. Moons

A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients

Veerle Lejon, Philippe Büscher, E. Magnus et al. · Acta Tropica · 1998 · 49 citations

African Trypanosomiasis, Cerebrospinal Fluid, Parasitic Protozoa +8

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes

Susan Stienen, Khibar Salah, A.H.M. Moons et al. · American Heart Journal · 2014 · 37 citations

Heart Failure, Prima Ii, Cardiovascular Disease +8

Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin‐10 response in human endotoxemia

A C J M de Pont, A.H.M. Moons, Evert de Jonge et al. · Journal of Thrombosis and Haemostasis · 2004 · 36 citations · Full text

Inflammation, Thrombosis, Human Endotoxemia +10

Recombinant Nematode Anticoagulant Protein c2, a Novel Inhibitor of Tissue Factor-Factor VIIa Activity, Abrogates Endotoxin-Induced Coagulation in Chimpanzees

A.H.M. Moons, Ron J.G. Peters, Hugo Ten Cate et al. · Thrombosis and Haemostasis · 2002 · 27 citations

External Validation of the ELAN‐HF Score, Predicting 6‐Month All‐Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

Khibar Salah, Susan Stienen, A.H.M. Moons et al. · Journal of the American Heart Association · 2019 · 10 citations · Full text